Dr. Robert Malone Comments on Ultralow Absolute Risk Reductions in COVID-19 mRNA Vaccines

Dr. Robert Malone Comments on Ultralow Absolute Risk Reductions in COVID-19 mRNA Vaccines

Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite.

Dr. Ron Brown – Opinion Editorial

September 10, 2021

Dr. Robert Malone, who helped develop the mRNA technology that was eventually applied in the Pfizer and Moderna COVID-19 vaccines, had a few words to say on the vaccines’ ultralow absolute risk reductions. In "Injections & Injunctions," Dr. Malone responded to a question about vaccine efficacy involving relative risk and absolute risk reductions: “There’s this whole discussion…is it really a ninety-plus percent improvement over controls, or is it a one or two percent improvement over controls in terms of the protection for disease and death afforded? There’s some evidence…there’s some, what appears to be some kind of convenient massaging of data—manipulating of data and selection of reporting measures. But for sure, we can say that there is now reasonable evidence that there is protection from disease and death.”

Here, Dr. Malone compares statistical findings of questionable vaccine efficacy in randomized controlled trials versus established observational evidence of vaccine effectiveness in r...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee